New Ruling in Reglan Lawsuits
Reglan, a prescription drug for the treatment of gastrophageal reflux, has been linked to some pretty averse side effects. Some of the known side effects include Tardivie Dyskinesia, Neuroleptic Malignant Syndrome, delirium, fever and unstable blood pressure.
A recent ruling from the California Court of Appeal holds Wyeth, makers of Reglan, responsible for even the generic version of Reglan, metoclopramide, reports Jim Porter of SierraSun.com.
‘Disclaimer Leads to Lawsuit’
Porter describes the proceedings that led up to this ruling in an article featured on SierraSun.com. A summary of the details is provided here. Elizabeth Conte filed a suit against Wyeth after suffering severe neurological disorder attributed to the taking of metoclopramide.
One of the factors underlying the claim is that the risk of serious side effects is substantially understated in the generic drug’s label. Wyeth claimed that the Conte’s physician was at fault for not relying on the warnings under Reglan’s label which supposedly clearly state the risks.
Ruling Regarding Generics
Porter writes that the Court of Appeal reached a conclusion that Wyeth was still responsible for disseminating accurate warning labels. Porter quotes the ruling as follows:
“Wyeth owes a duty of due care to those people it should reasonably foresee are likely to ingest metoclopramide in either the name-brand or the generic version when it is prescribed by their physicians in reliance on Wyeth’s representations (for the name-brand product).”
It is still up in the air whether or not Wyeth will appeal the ruling to the California Supreme Court, Porter goes on to say. Regardless, this is an important ruling for ongoing Reglan litigation.
Attorneys, like Porter and those at Nadrich & Cohen, continue to investigate claims made against the makers of Reglan and metoclopramide. If you have suffered from the severe side effects of either of these, contact the Reglan lawyers of Nadrich & Cohen to see if you are entitled to a settlement.